METHOD OF EXCHANGING ANIONS OF INORGANIC HALIDE PEROVSKITE NANOPARTICLES USING CATIONIC EFFECT

Abstract

Disclosed is a method of exchanging the anions of inorganic halide perovskite nanoparticles using cationic effect. More particularly, the method is a cation effect-based anion exchange method of being capable of improving optical stability while controlling the optical band energy of CsPbBr.sub.3 perovskite nanoparticles at room temperature. According to an embodiment of the present disclosure, a cation-anion pair suitable for anion exchange and stability improvement can be provided.

Claims

1. A method of exchanging anions of inorganic halide perovskite nanoparticles, the method comprising: synthesizing first inorganic halide perovskite nanoparticles of Formula 1 below in which defects are formed; preparing a solution by mixing a halogen salt of Formula 2 below with a polar solvent; and adding the first inorganic halide perovskite nanoparticles to the solution to synthesize second inorganic halide perovskite nanoparticles of Formula 3 below, wherein a bond between AB-X′.sub.3 of the second inorganic halide perovskite nanoparticles is stronger than a bond between C—X′ of the halogen salt, so that the anion X of the first inorganic halide perovskite nanoparticles is substituted with the anion X′ of the halogen salt, [Formula 1]
ABX.sub.3 [Formula 2]
CX′ [Formula 3]
ABX′.sub.3 (in Formulas 1 to 3, A is Cs or CH.sub.3NH, B is Pb or Sn, X and X′ are halogen anions, C is any one selected from among Cs.sup.+, Na.sup.+, K.sup.+, NH.sub.4.sup.+ and TBA.sup.+, and X and X′ are different from each other).

2. The method according to claim 1, wherein in the synthesizing of the second inorganic halide perovskite nanoparticles, cations of the halogen salt are attached to defects of the first inorganic halide perovskite nanoparticles to form nucleation sites.

3. The method according to claim 1, wherein the second inorganic halide perovskite nanoparticles has a grain size of 10 nm to 20 nm.

4. The method according to claim 1, wherein the synthesizing of the first inorganic halide perovskite nanoparticles is performed at 10° C. to 30° C.

5. The method according to claim 1, wherein the first inorganic halide perovskite nanoparticles of Formula 1 are CsPbBr.sub.3.

6. The method according to claim 1, wherein the halogen salt is NaI or NH.sub.4Cl.

7. The method according to claim 1, wherein a concentration of the halogen salt is 10 mM to 100 mM.

8. The method according to claim 1, wherein the polar solvent is IPA.

9. The method according to claim 1, wherein the second inorganic halide perovskite nanoparticles exhibit colloidal stability, so that ligand distribution on surfaces of the nanoparticles is maintained at 60% to 90% in the polar solvent.

10. Inorganic halide perovskite nanoparticles anion-exchanged according to the method of claim 1, wherein the anion-exchanged inorganic halide perovskite nanoparticles are CsPbI.sub.3.

11. Inorganic halide perovskite nanoparticles anion-exchanged according to the method of claim 1, wherein the anion-exchanged inorganic halide perovskite nanoparticles are CsPbC1.sub.3.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0027] The above and other objects, features and other advantages of the present disclosure will be more clearly understood from the following detailed description taken in conjunction with the accompanying drawings, in which:

[0028] FIG. 1A is a photo showing the emission color characteristics according to a change in the halogen composition of CsPbX.sub.3 perovskite, FIG. 1B illustrates a cubic structure model of CsPbX.sub.3 perovskite, and FIG. 1C is a photo using CsPbX.sub.3 perovskite;

[0029] FIG. 2 is a diagram illustrating a method of synthesizing the first inorganic halide perovskite CsPbBr.sub.3 using the re-crystallization method (ligand-assisted re-crystallization method) using a ligand according to Example 1;

[0030] FIG. 3 is a diagram comparing the soft/hard degree of cations and anions of halogen salts;

[0031] FIG. 4 is a graph showing the relative photoluminescence intensity of CsPbBr.sub.3 perovskite nanoparticles over time;

[0032] FIGS. 5A and 5B are graphs showing X-ray diffraction patterns (XRD) of the first inorganic halide perovskite nanoparticles before anion exchange and the second inorganic halide perovskite nanoparticles whose anions are exchanged;

[0033] FIG. 6A is a graph showing absorption spectra of CsPbBr.sub.3 perovskite nanoparticles and CsPbBr.sub.3 perovskite nanoparticles to which a halogen salt containing Cl anions is added, and FIG. 6B is a graph showing photoluminescence spectra when a halogen salt is added;

[0034] FIG. 7A is a graph showing absorption spectra of CsPbBr.sub.3 perovskite nanoparticles and CsPbBr.sub.3 perovskite nanoparticles to which a halogen salt containing I anions is added, and FIG. 7B is a graph showing photoluminescence spectra when a halogen salt is added;

[0035] FIG. 8 is a graph illustrating the photoluminescence measurement results of CsPbBr.sub.3 perovskite nanoparticles;

[0036] FIGS. 9A and 9B illustrate photoluminescence spectra when each halogen salt is added by concentration;

[0037] FIG. 10 is a diagram illustrating the principle that the cations of a halogen salt applied to CsPbBr.sub.3 perovskite nanoparticles act on defects;

[0038] FIG. 11 illustrates transmission electron microscope photographs of inorganic halide perovskite nanoparticles according to embodiments;

[0039] FIG. 12 illustrates the photoluminescence of CsPbBr.sub.3 and anion-exchanged CsPbBr.sub.3 in each container; and

[0040] FIGS. 13A to 13D illustrate the absorption spectra of perovskite nanoparticles.

DETAILED DESCRIPTION OF THE DISCLOSURE

[0041] The present disclosure will now be described more fully with reference to the accompanying drawings and contents disclosed in the drawings. However, the present disclosure should not be construed as limited to the exemplary embodiments described herein.

[0042] The terms used in the present specification are used to explain a specific exemplary embodiment and not to limit the present inventive concept. Thus, the expression of singularity in the present specification includes the expression of plurality unless clearly specified otherwise in context. It will be further understood that the terms “comprise” and/or “comprising”, when used in this specification, specify the presence of stated components, steps, operations, and/or elements, but do not preclude the presence or addition of one or more other components, steps, operations, and/or elements thereof.

[0043] It should not be understood that arbitrary aspects or designs disclosed in “embodiments”, “examples”, “aspects”, etc. used in the specification are more satisfactory or advantageous than other aspects or designs.

[0044] In addition, the expression “or” means “inclusive or” rather than “exclusive or”. That is, unless otherwise mentioned or clearly inferred from context, the expression “x uses a or b” means any one of natural inclusive permutations.

[0045] In addition, as used in the description of the disclosure and the appended claims, the singular form “a” or “an” is intended to include the plural forms as well, unless context clearly indicates otherwise.

[0046] A “defect” refers to a portion, in which the periodicity of atom arrangement is broken, in a perovskite crystal composed of a periodic arrangement of atoms.

[0047] In anion exchange of the present disclosure, “exchange” and “substitution” are used interchangeably.

[0048] The present disclosure will now be described more fully with reference to the accompanying drawings.

[0049] FIG. 1A is cited from Joule, 2018, 2 (10), 2105-2116, and FIG. 1C is cited from Nature Nanotechnology, 2014, 9, 687-692.

[0050] Perovskite is a material that is spotlighted in the optical field, and emits light in various visible light regions as shown in FIG. 1A through bandgap adjustment.

[0051] Referring to FIG. 1B, inorganic halide perovskite CsPbX.sub.3 (X=Cl, Br, I) has a cubic structure, the blue sphere outside the octahedron represents Cs, the light blue sphere inside the octahedron represents Pb, and the red sphere at each vertex of the octahedron represents X.

[0052] The inorganic halide perovskite CsPbX.sub.3 may be applied to LEDs and solar cells as shown in FIG. 1C (left: emits red light, right: emits green light) and the like. CsPbX.sub.3 has advantages in that it has a direct bandgap due to a high emission quantum yield (PLQY), high ion mobility, and a cubic structure. That is, CsPbX.sub.3 exhibits high luminous efficiency because non-radiative recombination does not occur due to the direct bandgap. However, red-emitting CsPbI.sub.3 and blue-emitting CsPbC1.sub.3 do not have a thermodynamic cubic structure when synthesized by an existing hot-injection method, and due to these structural problems, an indirect bandgap and electron loss appear at room temperature. Accordingly, luminous efficiency is decreased.

[0053] Anion-exchanged inorganic halide perovskite nanoparticles CsPbC1.sub.3 and CsPbI.sub.3 may be used in a photodetector. In addition, since CsPbI.sub.3 perovskite with secured stability has a multi-layer structure, it may be used in LEDs and solar cells that must be able to withstand processing with various materials.

[0054] Therefore, it is necessary to control a bandgap by an anion exchange method. By an anion exchange method, the direct bandgap of CsPbBr.sub.3 can be maintained, the entire visible light range can be covered, and the proportion of halide can be easily controlled. Anion exchange usually occurs in a solution state. At this time, a polar solvent is used to ionize a halide solute that is a target of exchange, and perovskite nanoparticles should be passivated.

[0055] On the other hand, inorganic perovskite has a problem in that device performance is reduced due to defects in the material itself, so defect control is essential to manufacture high-performance perovskite solar cells. Conventionally known anion exchange methods have a problem in stability due to defects caused by polar solvents. Since additional processes such as doping are required to control defects, the process is lengthy and inefficient. To achieve defect control while performing anion exchange, the present disclosure uses the hard-soft acid-base (HSAB) theory. Hereinafter, it is referred to as the HSAB theory. By using the HSAB theory, perovskite may be passivated with the cations of a target halide to prevent a phase change from occurring, and colloidal stability may be maintained because a surface ligand is not affected.

[0056] Specifically, the method of exchanging anions of inorganic halide perovskite nanoparticles of the present disclosure is largely divided into two steps. The first step is a step of synthesizing first inorganic halide perovskite nanoparticles with defects having an ABX.sub.3 (A is Cs or CH.sub.3NH, B is Pb or Sn, and X is a halogen anion) composition. The second step is a step of preparing a solution by mixing a halogen salt having a CX′ (C is any one selected from among Cs.sup.+, Na.sup.+, K.sup.+, NH.sub.4.sup.+ and TBA.sup.+, X′ is a halogen anion, and X and X′ are different from each other) composition and a polar solvent and adding the first inorganic halide perovskite nanoparticles to the solution to synthesize second inorganic halide perovskite nanoparticles having an ABX′3 composition. By the method of exchanging anions of inorganic halide perovskite nanoparticles, the bond between AB-X′3 of the second inorganic halide perovskite nanoparticles is stronger than the bond between C—X′ of the halogen salt, so that the anion X of the first inorganic halide perovskite nanoparticles is substituted with the anion X′ of the halogen salt.

[0057] In the first step of synthysizing inorganic halide perovskite nanoparticles, first inorganic halide perovskite nanoparticles having ABX.sub.3 composition may be preferably CsPbBr.sub.3. The synthesis is performed at 10° C. to 30° C., preferably 25° C. The synthesis of the inorganic halide perovskite is performed at room temperature to form a number of defects on the surface of the first inorganic halide perovskite nanoparticles using a ligand-assisted re-crystallization method.

[0058] While the crystal structure of inorganic halide perovskite having many defects cannot be maintained for a day due to poor oxidative stability and, when a polar solvent is added, cannot withstand even a few minutes and is destroyed, the present disclosure overcomes the problems through the cationic effect. In summary, it is a unique feature of the present disclosure that defects are artificially induced by a room-temperature solution process method so as to further maximize the cationic effect.

[0059] In the second step of synthesizing second inorganic halide perovskite nanoparticles by adding the first inorganic halide perovskite nanoparticles to a solution in which a halogen salt and a polar solvent are mixed, the halogen salt may be NaI or NH.sub.4Cl. The reason why anion exchange occurs well when NaI or NH.sub.4Cl is used as a cation-anion combination of a halogen salt can be explained by the HSAB theory. According to the theory, since TBAC or NaI is well ionized, cations exhibit a cationic effect in the defects of the first inorganic halide perovskite, and are suitable for anion substitution. However, anion exchange does not actually occur when TBAC is used although this is an example applied to NaI. The reason is that TBA.sup.+ cannot passivate defects on the surface of perovskite due to the large molecular size thereof. Therefore, the next most ionizable combination, NH.sub.4Cl, is selected for anion exchange.

[0060] In addition, the concentration of the halogen salt is 10 mM to 100 mM, preferably 20 mM to 40 mM. When the concentration of the halogen salt is less than 10 mM, the surface defects of the perovskite nanoparticles are not protected by the cations of the halogen salt, so the nanoparticles are unstable and may be destroyed. Accordingly, the anion exchange of the perovskite does not occur well. On the other hand, when the concentration of the halogen salt is 100 mM or more, anion exchange occurs too quickly due to the high concentration, making it difficult to control the halogen composition of the inorganic halide perovskite.

[0061] In the solution in which the halogen salt and a polar solvent are mixed, the polar solvent is preferably IPA. When the polarity of water is 100, IPA has a moderate polarity of about 54, so IPA has the characteristics of both a polar solvent and a non-polar solvent. In addition, IPA can be dissociated in the form of RO— to promote the ionization and cationic effect of a solute, so it can help anion exchange unlike other polar solvents.

[0062] In the process of exchanging anions, the cations of the halogen salt are attached to the defects of the first inorganic halide perovskite nanoparticles and act as nucleation sites. The cations serving as the nucleation point of the first inorganic halide perovskite nanoparticles become additional growth points of the second inorganic halide perovskite nanoparticles. The second inorganic halide perovskite nanoparticles grown in this way have a grain size of 10 nm to 20 nm. In a solar cell, the grain size of a material is very important for electron/hole mobility, and such growth may increase the grain size, thereby improving the performance of optical and optoelectronic devices.

[0063] In addition, the cations serve to increase the stability of the perovskite structure by reducing surface defects. The roles of cations as described above are collectively referred to as “cationic effect.” The second inorganic halide perovskite nanoparticles exhibit colloidal stability even in a polar solvent due to the cationic effect. The term “colloidal stability” means that perovskite nanoparticles in a solution are well wrapped with oleic acid (OA) and oleylamine (OAm) ligands used for synthesis. Originally, perovskite nanoparticles have very poor colloidal stability because the perovskite nanoparticles occupy a place where oxygen should have been combined with oleic acid or oleylamine in an oxygen environment. changed or decomposed, and are converted into a bulk material or decomposed within one to one week after the perovskite is synthesized.

[0064] In the present disclosure, it can be seen that colloidal stability is maintained in that the ligand distribution on the surfaces of the second inorganic halide perovskite particles is maintained in a range of 60% to 90% in the polar solvent. As such, since the colloidal stability of the perovskite nanoparticles is maintained, a solution process may be used for synthesizing the perovskite. That is, a thin-film device can be simply manufactured through spin coating after spraying a solution on a desired substrate, and a large-area device can also be manufactured using the thin-film device.

[0065] Hereinafter, the present disclosure will be described in more detail with reference to the following Examples. It will be apparent to those skilled in the art that Examples are merely for concretely explaining the disclosure and therefore, there is no intent to limit the disclosure to Examples.

[Comparative Example 1] Synthesis of CsPbBr.SUB.3 .Nanoparticles—High Temperature

[0066] 200 mg of CsCO.sub.3, 10 ml of 1-Octadecene (1-ODE), and 0.6 ml of oleic acid (OA) were put into a 25 ml 3-neck flask, and then vacuum was held at 120° C. for 1 hour with stirring. Next, Ar flowed and the temperature was maintained at 150° C. for 20 minutes to synthesize Cs-oleate, and the temperature was lowered to 70 to 110° C.

[0067] 655 mg of PbBr.sub.2, 50 ml of 1-ODE, 5 ml of oleic acid, and 5 ml of oleylamine (OAm) were put into a 100 ml three-necked flask, and then vacuum was held at 120° C. for 1 hour with stirring. Next, Ar flowed and the temperature was raised to 130 to 170° C., and then the previously synthesized Cs-oleate was injected to maintain the temperature for 10 minutes, and then heating was terminated.

[0068] The synthesized perovskite CsPbBr.sub.3 nanoparticles were centrifuged with an excess of anti-solvent to sink, and then the supernatant was removed and dispersed in an organic solvent.

[0069] Comparative Example 1 corresponds to a method of synthesizing CsPbBr.sub.3 perovskite using a hot injection method, and since the synthesis is performed at a high temperature, it shows very few defects and thus has high stability.

[Example 1] Synthesis of CsPbBr.SUB.3 .Nanoparticles—Room Temperature

[0070] A CsPbBr.sub.3 precursor was prepared by adding CsBr and PbBr.sub.2 to an N,N-dimethylformamide (DMF) solvent and then stirring for at least one day. The CsPbBr.sub.3 precursor was mixed with organic ligands, oleic acid, and oleylamine, and an organic solvent, toluene, was added thereto, thereby preparing a mixed solution. The mixed solution was stirred for 2 minutes to synthesize CsPbBr.sub.3 perovskite nanoparticles in a colloidal state.

[0071] The CsPbBr.sub.3 perovskite nanoparticles in the colloidal state were mixed with a methyl acetate solvent and centrifuged such that the nanoparticles had a uniform size. Next, the sunken perovskite nanoparticles were discarded, and particles of uniform size were collected. A colloidal CsPbBr.sub.3 perovskite nanoparticle solution was prepared by dispersing the uniform perovskite nanoparticles in hexane.

[0072] Since the hexane is a non-polar solvent, it is possible to well disperse the perovskite nanoparticles surrounded by oleic acid and oleamine which are non-polar due to a long carbon chain. Accordingly, an even thin film can be produced when manufacturing a device in a subsequent process.

[0073] CsPbBr.sub.3 nanoparticles synthesized according to Example 1 had defects on the surfaces thereof. The defects are shown by the circular dotted line on the right side of FIG. 10.

[Comparative Example 2-1] Anion Exchange— TBAC

[0074] A halogen salt TBAC was prepared for anion exchange of the perovskite nanoparticles synthesized according to Example 1. Each halogen salt solute was dissolved in an iso-propanol (IPA) solvent to a concentration of 30 mM. The dissolved halide solution was mixed with a solution of colloidal CsPbBr.sub.3 perovskite nanoparticles dissolved in hexane as an organic solvent.

[Comparative Example 2-2] Anion Exchange—NaCl

[0075] The experiment was carried out in the same manner as in Comparative Example 2-1, except that NaCl was used instead of TBAC as the halogen salt in Comparative Example 2-1.

[Comparative Example 2-3] Anion Exchange— TBAI

[0076] The experiment was carried out in the same manner as in Comparative Example 2-1, except that TBAI was used instead of TBAC as the halogen salt in Comparative Example 2-1.

[Comparative Example 2-4] Anion Exchange— MIA

[0077] The experiment was carried out in the same manner as in Comparative Example 2-1, except that NH.sub.4I was used instead of TBAC as the halogen salt in Comparative Example 2-1.

[Example 2-1] Anion Exchange—NH.SUB.4.Cl

[0078] The experiment was carried out in the same manner as in Comparative Example 2-1, except that NH.sub.4Cl was used instead of TBAC as the halogen salt in Comparative Example 2-1.

[Example 2-2] Anion Exchange—NaI

[0079] The experiment was carried out in the same manner as in Comparative Example 2-1, except that NaI was used instead of TBAC as the halogen salt in Comparative Example 2-1.

[0080] Examining the results of anion exchange conducted according to Comparative Examples 2-1 to 2-4 and Examples 2-1 and 2-2, anion exchange was successful only in Example 2-1 (using NH.sub.4Cl as a halogen salt) and Example 2-2 (using NaI as a halogen salt), so that CsPbI.sub.3 and CsPbBr.sub.3 perovskite nanoparticles were respectively produced. In the remaining mixed solutions, no anion exchange was observed.

[0081] FIG. 2 is a diagram illustrating a method of synthesizing the first inorganic halide perovskite CsPbBr.sub.3 using the re-crystallization method (ligand-assisted re-crystallization method) according to Example 1. In the case of the hot injection method among inorganic halide perovskite synthesis methods, synthesis is performed at 150° C. or higher and very few defects are generated, so that highly stable perovskite can be synthesized. The present disclosure uses a room temperature solution process method of performing synthesis at room temperature of about 25° C. under atmospheric conditions, unlike the hot injection method, to artificially induce defects and further maximize the cationic effect. When manufacturing a perovskite-based optical and optoelectronic device using the solution process, the cost can be greatly reduced because mass production is easy and it is possible to manufacture a large area.

[0082] Referring to FIG. 2, the drawing on the left shows a mixture prepared by adding CsBr and PbBr.sub.2 to a dimethylformamide (DMF) solvent, and then mixing the same with organic ligands oleic acid (OA) and oleylamine (OAm), and then adding the same to an organic solvent, toluene. Colloidal CsPbBr.sub.3 perovskite nanoparticles (CPB) illustrated in the drawing on the right by stirring the mixture are synthesized. The synthesized CsPbBr.sub.3 nanoparticles have many defects on the surfaces thereof.

[0083] In FIG. 3, soft/hard degrees are compared for various ions. A compound having a small size, high charge state, and weak polarity is called “hard”, and a compound having a large size, low charge state, and strong polarity is called “soft”. According to the hard-soft acid-base (HSAB) theory, soft acids react faster with soft bases and form stronger bonds therewith, and the same applies to hard acids and hard bases.

[0084] Referring to FIG. 3, it can be seen that the hard bases (hard cations) are in the order of TBA.sup.+, NH4.sup.+, and Na.sup.+, and the hard acids (hard anions) are in the order of I.sup.−, Br.sup.−, and Cl.sup.−. If applying the HSAB theory to this, it can be predicted that a combination of hard cations—hard anions or a combination of soft cations—soft anions has strong bonds, so it is difficult to ionize the combinations, and conversely, a combination of hard cations—soft anions or a combination of soft anions—hard cations has good ionization.

[0085] Therefore, ionization would occur well in the order of TBAC, NH.sub.4Cl, and NaCl among cation-anion combinations (halogen salt combinations) containing Cl anions, and ionization would occur well in the order of NaI, NH.sub.4I, and TBAI among cation-anion combinations (halogen salt combinations) containing I anions. The better the ionization, the better the halogen anions can be provided to the inorganic halide perovskite.

[0086] FIG. 4 is a graph illustrating relative photoluminescence intensity over time. Referring to the graph, the yellow-green line, Colloidal CPB PeNCs, means CsPbBr.sub.3 perovskite dispersed in a solution. The cyan line, Adding IPA in CPB PeNCs, means that IPA was added to the CsPbBr.sub.3 perovskite in a colloidal state. The CsPbBr.sub.3 perovskite in the colloidal state has little change in photoluminescence intensity over time. On the other hand, it can be seen that the photoluminescence intensity of CsPbBr.sub.3 perovskite nanoparticles to which IPA was added rapidly decreases over time. In general, polar solvents such as methanol, ethanol, and IPA are considered harsh chemicals that cause defects in the structure of CsPbBr.sub.3 perovskite and eventually destroy perovskite nanoparticles. Here, “destroy” has the following meanings. The “destroy” means that the oleic acid and oleylamine ligands cannot bind to the surfaces of the nanoparticles due to the defects so that the nanoparticles are agglomerated and become a bulk material of several micrometers or more. It also means that the nanoparticles are decomposed and specific physical properties or specific structures do not appear.

[0087] In the present disclosure, IPA serves two roles. First, as described above, a polar solvent, IPA, induces defects in the perovskite structure and creates many defect sites, thereby making the cations of the halogen salt more actively passivate. Second, as IPA has a medium polarity while ionizing a halogen salt into cations and anions, it serves to allow the cations and anions to access the perovskite nanoparticles bound to oleic acid and oleylamine ligands in a non-polar hexane solution.

[0088] Hereinafter, drawings are briefly described.

[0089] In FIGS. 9A, 9B and 13A to 13D, CPB means CsPbBr.sub.3, CPC means CsPbC1.sub.3, and CPI means CsPbI.sub.3.

[0090] In FIGS. 13A to 13D, PeNCs means perovskite nanoparticles.

[0091] In FIGS. 5A, 5B, 6A, 6B, 7A, 7B, 8, 9A, 9B, 11, 13A and 13D, “As-synthesized” means CsPbBr.sub.3 to which a halogen salt is not applied, which corresponds to Example 1.

[0092] In FIGS. 5A, 6A, and 6B, “TBAC-treatment (treated)” means CsPbBr.sub.3 perovskite nanoparticles treated with TBAC, which corresponds to Comparative Example 2-1.

[0093] In FIGS. 5A, 6A, and 6B, “NaCl-treatment (treated)” means CsPbBr.sub.3 perovskite nanoparticles treated with NaCl, which corresponds to Comparative Example 2-2.

[0094] In FIGS. 5B, 7A, and 7B, “TBAI-treatment (treated)” means CsPbBr.sub.3 perovskite nanoparticles treated with TBAI, which corresponds to Comparative Example 2-3.

[0095] In FIGS. 5B, 7A, and 7B, “NH.sub.4I-treatment (treated)” means CsPbBr.sub.3 perovskite nanoparticles treated with NH.sub.4I, which corresponds to Comparative Example 2-4.

[0096] In FIGS. 5A, 6A, 6B, 11, 13C and 13D, NH.sub.4Cl-treatment (treated) means CsPbBr.sub.3 perovskite nanoparticles treated with NH.sub.4Cl, which corresponds to Example 2-1.

[0097] In FIGS. 5B, 7A, 7B, 11, 13B and 13D, “NaI-treatment (treated)” means CsPbBr.sub.3 perovskite nanoparticles treated with NaI, which corresponds to Example 2-2.

[0098] In FIG. 8, “TBAB-treated” means CsPbBr.sub.3 perovskite nanoparticles treated with TBAB.

[0099] In FIG. 8, “KBr-treated” means CsPbBr.sub.3 perovskite nanoparticles treated with KBr.

[0100] In FIG. 8, “NaBr-treated” means CsPbBr.sub.3 perovskite nanoparticles treated with NaBr.

[0101] In FIG. 8, “NH.sub.4Br-treated” means CsPbBr.sub.3 perovskite nanoparticles treated with NH.sub.4Br.

[0102] In FIG. 9A, “0.3 mM NH.sub.4Cl-treated CPB” means CsPbBr.sub.3 perovskite nanoparticles treated with 0.3 mM NH.sub.4Cl.

[0103] In FIG. 9A, “3 mM NH.sub.4Cl-treated CPB” means CsPbBr.sub.3 perovskite nanoparticles treated with 3 mM NH.sub.4Cl.

[0104] In FIG. 9A, “30 mM NH.sub.4Cl-treated CPB” means CsPbBr.sub.3 perovskite nanoparticles treated with 30 mM NH.sub.4Cl.

[0105] In FIG. 9B, “0.3 mM NaI-treated CPB” means CsPbBr.sub.3 perovskite nanoparticles treated with 0.3 mM NaI.

[0106] In FIG. 9B, “3 mM NaI-treated CPB” means CsPbBr.sub.3 perovskite nanoparticles treated with 3 mM NaI.

[0107] In FIG. 9B, “30 mM NaI-treated CPB” means CsPbBr.sub.3 perovskite nanoparticles treated with 30 mM NaI.

[0108] FIGS. 5A and 5B are graphs showing X-ray diffraction patterns (XRD) of the first inorganic halide perovskite nanoparticles before anion exchange and the second inorganic halide perovskite nanoparticles whose anions are exchanged. Referring to the graph on the left, the X-ray diffraction patterns are shown in the order of CsPbBr.sub.3 perovskite nanoparticles, to which NH4Cl, NaCl, and TBAC are respectively added, and CsPbBr.sub.3 perovskite nanoparticles before the addition of halogen salt from above. Referring to the graph on the right, the X-ray diffraction patterns are shown in the order of CsPbBr.sub.3 perovskite nanoparticles, to which NH4I, NaI, and TBAI are respectively added, and CsPbBr.sub.3 perovskite nanoparticles before the addition of halogen salt from above. When treated with NH.sub.4Cl and NaI, the anion-exchanged CsPbC1.sub.3 and CsPbI.sub.3 show the same cubic structure peak as CsPbBr.sub.3. On the other hand, when treated with TBAC and TBAI, both the structures are destroyed and decomposed, and therefore no peaks appear. When treated with NaCl and NH.sub.4I, it can be seen that the cubic structure is destroyed and transformed into another structure such as an orthorhombic system.

[0109] FIG. 6A is a graph showing absorption spectra of CsPbBr.sub.3 perovskite nanoparticles and CsPbBr.sub.3 perovskite nanoparticles to which a halogen salt containing Cl anions is added. FIG. 6B is a graph showing photoluminescence (PL) spectra of CsPbBr.sub.3 perovskite nanoparticles and CsPbBr.sub.3 perovskite nanoparticles to which a halogen salt containing Cl anions is added. The photograph in the upper right of FIG. 6b shows an inorganic halide perovskite under photoluminescence.

[0110] Referring to FIGS. 6A and 6B, absorption and photoluminescence spectra of CsPbBr.sub.3 perovskite nanoparticles before halogen salt addition and CsPbBr.sub.3 perovskite nanoparticles added with each of TBAC, NH.sub.4Cl, and NaCl are shown. In FIGS. 6A and 6B, the CsPbBr.sub.3 perovskite nanoparticles added with NH.sub.4Cl will have a blue color because a peak appears at a wavelength of around 450 nm, which can be seen in the center of the photo in the upper right of FIG. 6B. The CsPbBr.sub.3 perovskite nanoparticles added with NaCl and the CsPbBr.sub.3 perovskite nanoparticles before addition of a halogen salt will emit green light because a peak appears at a wavelength of around 500 nm, which can be seen on the right side of the photo. The CsPbBr.sub.3 perovskite nanoparticles added with TBAC undergo anion exchange, but are rapidly destroyed because defect passivation is impossible due to the large size of TBA.sup.+. Therefore, a small peak that it is difficult to identify appears at a wavelength around 400 nm. In the case of the TBAC-treated peak in FIG. 6B, the peak at the violet wavelength is prominent because normalization was performed, but there is actually no color as shown on the left side of the photo.

[0111] In inorganic halide perovskite, the band gap is adjusted according to the type of halogen it possesses, and the color of the emitted light changes. Therefore, it can be known through the wavelength of absorbed light whether the anion exchange has been successful. When NH.sub.4Cl is added to greenish CsPbBr.sub.3 perovskite nanoparticles, blue appears, which indicates that anions are exchanged from Br to Cl.sup.− to form CsPbC1.sub.3 perovskite nanoparticles. However, when NaCl is added, an anion is not exchanged with Cl.sup.− so the green color of the existing CsPbBr.sub.3 perovskite appears. When TBAC is added, the perovskite structure is destroyed and no color appears.

[0112] Based on the HSAB theory, anion exchange should be best performed when TBAC is added, but TBA.sup.+ cannot passivate the defects of the perovskite due to the large molecular size thereof. When NH.sub.4Cl, which ionizes well next to TBA.sup.+, was added, anion exchange was easily performed. Accordingly, it can be confirmed that the molecular size also affects the cation effect. In addition, when NaCl is added, the provision of halogen anions does not occur well because it is a combination of hard acid-hard anions, indicating that anion exchange has failed.

[0113] FIG. 7A is a graph showing absorption spectra of CsPbBr.sub.3 perovskite nanoparticles and CsPbBr.sub.3 perovskite nanoparticles to which a halogen salt containing I anions is added. FIG. 7B is a graph showing photoluminescence (PL) spectra of CsPbBr.sub.3 perovskite nanoparticles and CsPbBr.sub.3 perovskite nanoparticles to which a halogen salt containing I anions is added. The photograph in the upper right of FIG. 7b shows an inorganic halide perovskite under photoluminescence.

[0114] Referring to FIGS. 7A and 7B, the absorption and photoluminescence spectra of CsPbBr.sub.3 perovskite nanoparticles added with each of TBAI and NH.sub.4I, CsPbBr.sub.3 perovskite nanoparticles before the addition of a halogen salt, and CsPbBr.sub.3 perovskite nanoparticles added with NaI are shown. In FIGS. 7A and 7B, the CsPbBr.sub.3 perovskite nanoparticles added with TBAI and the CsPbBr.sub.3 perovskite nanoparticles added with NH.sub.4I show no peak. It can be seen that the CsPbBr.sub.3 perovskite nanoparticles before the addition of a halogen salt emit green light because a peak appears at a wavelength of around 500 nm, and the CsPbBr.sub.3 perovskite nanoparticles added with NaI emit red light because a peak appears at a wavelength of around 660 nm. This can also be confirmed in the upper right photo of FIG. 7B. TBAI, NH.sub.4I, and NaI are placed sequentially from the left, TBAI and NH.sub.4I do not emit light, and NaI emits red light.

[0115] According to the HSAB theory, I anion exchange was successfully performed when NaI, which is well ionized, was added to the CsPbBr.sub.3 perovskite nanoparticles, confirming that the composition was changed to the red-colored CsPbI.sub.3 perovskite nanoparticles. TBAI cannot passivate defects due to the large size of TBA.sup.+, and NH.sub.4I cannot fill defect sites because they ionize well, and peaks do not appear because the particles are destroyed by the polar solvent.

[0116] FIG. 8 is a graph of illustrating the photoluminescence measurement results of CsPbBr.sub.3 perovskite nanoparticles.

[0117] FIG. 8 illustrates the results of adding TBAB, KBr, NaBr, and NH.sub.4Br having Br ions, which are halide ions of CsPbBr.sub.3, and having different cations. The y-axis of the graph appears as + when the wavelength is red-shifted from the existing peak in photoluminescence (PL), and—when the wavelength is blue-shifted. When there is no change in the halide of the perovskite, the red shift of the nanoparticles means that the size of the nanoparticles increases, and the blue shift means that the particles become smaller. When each of KBr, NaBr, and NH.sub.4Br was added to the CsPbBr.sub.3 perovskite, a very fine red shift occurred. Through this, it can be seen that the cations of the halogen salt were bonded to the defect sites of the CsPbBr.sub.3 perovskite nanoparticles, resulting in fine growth. On the other hand, it was blue-shifted when TBAB was added.

[0118] Through this, it can be seen that the perovskite particles were destroyed because TBA.sup.+ could not bind to the defect sites of the perovskite due to the large size of TBA.sup.+.

[0119] Referring to FIG. 9A, 0.3 mM, 3 mM, and 30 mM NH.sub.4Cl were respectively used, and when 0.3 mM and 3 mM NH.sub.4Cl were respectively added to CsPbBr.sub.3 perovskite, graphs that are similar to the photoluminescence graph of CsPbBr.sub.3 perovskite to which a halogen salt is not added are shown. From this, it can be seen that Cl anion exchange did not occur. On the other hand, when 30 mM of H.sub.4Cl was added, the peak of the graph shifted from green 510 nm to blue 480 nm, which indicates that anion exchange into CsPbC1.sub.3 occurred.

[0120] Referring to FIG. 9B, 0.3 mM, 3 mM, and 30 mM NaI were respectively used, and when 0.3 mM and 3 mM NaI were respectively added to CsPbBr.sub.3 perovskite, graphs that are similar to the photoluminescence graph of CsPbBr.sub.3 perovskite to which a halogen salt is not added are shown. From this, it can be seen that I anion exchange did not occur. On the other hand, when 30 mM of NaI was added, the peak of the graph shifted from green 510 nm to red 650 nm, which indicates that anion exchange into CsPbI.sub.3 occurred.

[0121] FIG. 10 is a diagram illustrating the principle that the cations of a halogen salt applied to CsPbBr.sub.3 perovskite nanoparticles act on defects. Referring to FIG. 10, the cations bind to the surface defects of CsPbBr.sub.3 perovskite and passivate them to prevent penetration of the polar solvent, and furthermore, to protect the surface through perovskite particle growth.

[0122] FIG. 11 illustrates transmission electron micrographs of inorganic halide perovskite nanoparticles according to embodiments. The first photo shows CsPbBr.sub.3 nanoparticles synthesized according to Example 1, the second photo shows a case where CsPbBr.sub.3 is anion-exchanged into CsPbC1.sub.3 by adding NH.sub.4Cl according to Example 2-1, and the third photo shows a case where CsPbBr.sub.3 is anion-exchanged into CsPbI.sub.3 by adding NaI according to Example 2-2. Referring to FIG. 11, it can be seen that the lattice spacing is changed by anion exchange. The lattice spacing of the CsPbBr.sub.3 perovskite nanoparticles was 0.58 nm, the lattice spacing of Cl anion-exchanged CsPbI.sub.3 perovskite nanoparticles was decreased to 0.57 nm, and the lattice spacing of I anion-exchanged CsPbI.sub.3 perovskite nanoparticles was increased to 0.59 nm. The lattice spacing of nanoparticles was changed according to the size of Cl, Br, and I ions.

[0123] Through the cationic effect, the cations of the halogen salt fill the defects of the perovskite nanoparticles and act as nucleation sites, so that the growth of the particles occurs. Accordingly, the surface of the perovskite nanoparticles is passivated, and colloidal stability is also improved.

[0124] According to the cationic effect, the defective perovskite nanoparticles maintain colloidal stability even in IPA. Referring to the second and fourth photos of FIG. 12, it can be confirmed that the colloidal stability is maintained as all three colors appear in one container. The blue container in the first photo shows CsPbC1.sub.3 anion-exchanged from CsPbBr.sub.3, the green container in the third photo shows CsPbBr.sub.3, and the red container in the fifth photo shows CsPbI.sub.3 anion-exchanged from CsPbBr.sub.3.

[0125] FIGS. 13A to 13D illustrate the FT-IR graphs of CbPbBr.sub.3 perovskite nanoparticles. It can be seen through FT-IR whether colloidal stability is maintained in a solution. FIG. 13A illustrates an absorption spectrum of CsPbBr.sub.3 perovskite nanoparticles before anion exchange. FIG. 13B illustrates an absorption spectrum of CsPbBr.sub.3 perovskite nanoparticles, to which NaI is applied, and a Na.sup.+ peak, and FIG. 13C illustrates an absorption spectrum of CsPbBr.sub.3 perovskite nanoparticles, to which NH.sub.4Cl is added, and NH.sub.4.sup.+ peak. This indicates that anion exchange successfully occurred.

[0126] FIG. 13D is a combination of peaks in the range of 2900 to 3100 nm.sup.−1 in FIGS. 13A to 13C. In all three graphs, 2900 to 3100 nm.sup.−1 peaks appear, which means that C—H stretch bonding exists. That is, C—H stretch bonding was maintained even after anion exchange occurred. The anion exchange means that colloidal stability is maintained. To maintain colloidal stability, the perovskite nanoparticles in a solution should be well surrounded by oleic acid (OA) and oleylamine (OAm) ligands, so it can be seen that the bonding is C—H stretch bonding of oleic acid and oleylamine.

[0127] According to the present disclosure, the performance of optical and optoelectronic devices based on inorganic halide perovskite can be improved.

[0128] According to the present disclosure, the cost required for manufacturing perovskite-based optical and optoelectronic devices can be significantly reduced.

[0129] According to the present disclosure, since the colloidal stability of perovskite nanoparticles is maintained, a thin film-type and large-area device can be manufactured through a solution process.

[0130] Although the present disclosure has been described through limited examples and figures, the present disclosure is not intended to be limited to the examples. Those skilled in the art will appreciate that various modifications, additions and substitutions are possible, without departing from the scope and spirit of the disclosure. Therefore, it should be understood that there is no intent to limit the disclosure to the embodiments disclosed, rather, the disclosure is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the disclosure as defined by the claims.